Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 11;9(1):282.
doi: 10.1038/s41398-019-0625-0.

The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies

Affiliations
Review

The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies

Ying Han et al. Transl Psychiatry. .

Abstract

Fentanyl is a powerful opioid anesthetic and analgesic, the use of which has caused an increasing public health threat in the United States and elsewhere. Fentanyl was initially approved and used for the treatment of moderate to severe pain, especially cancer pain. However, recent years have seen a growing concern that fentanyl and its analogs are widely synthesized in laboratories and adulterated with illicit supplies of heroin, cocaine, methamphetamine, and counterfeit pills, contributing to the exponential growth in the number of drug-related overdose deaths. This review summarizes the recent epidemic and evolution of illicit fentanyl use, its pharmacological mechanisms and side effects, and the potential clinical management and prevention of fentanyl-related overdoses. Because social, economic, and health problems that are related to the use of fentanyl and its analogs are growing, there is an urgent need to implement large-scale safe and effective harm reduction strategies to prevent fentanyl-related overdoses.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Poklis A. Fentanyl: a review for clinical and analytical toxicologists. J. Toxicol. Clin. Toxicol. 1995;33:439–447. doi: 10.3109/15563659509013752. - DOI - PubMed
    1. Clotz, M. A. & Nahata, M. C. Clinical uses of fentanyl, sufentanil, and alfentanil. Clin. Pharm.10, 581–593 (1991). - PubMed
    1. Aldington D, Jagdish S. The fentanyl ‘lozenge’ story: from books to battlefield. J. R. Army Med. Corps. 2014;160:102–104. doi: 10.1136/jramc-2013-000227. - DOI - PubMed
    1. Stanley TH. The fentanyl story. J. Pain. 2014;15:1215–1226. doi: 10.1016/j.jpain.2014.08.010. - DOI - PubMed
    1. Schug SA, Ting S. Fentanyl formulations in the management of pain: an update. Drugs. 2017;77:747–763. doi: 10.1007/s40265-017-0727-z. - DOI - PubMed

Publication types

MeSH terms